Ryman Healthcare Limited

NZX:RYM.NZ

5.43 (NZD) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) NZD.

20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Revenue 650.534560.11503.758452.411422.111380.947340.57288.379260.063225.768201.894180.372154.122129.09109.08991.53174.725189.498142.246118.29794.91393.17258.6857.05345.97711.71
Cost of Revenue 695.686579.876501.936427.674377.865326.87288.62240.507172.316181.522154.54131.51600000000000000
Gross Profit -45.152-19.7661.82224.73744.24654.07751.9547.87287.74744.24647.35448.856154.122129.09109.08991.53174.725189.498142.246118.29794.91393.17258.6857.05345.97711.71
Gross Profit Ratio -0.069-0.0350.0040.0550.1050.1420.1530.1660.3370.1960.2350.27111111111111111
Reseach & Development Expenses 16.07311.7425.1065.1373.609000000000000000000000
General & Administrative Expenses 414.3440305.759265.494233.549212.514179.555149.299133.329118.29798.03985.67571.99360.38849.89444.44737.90900.6140.42500.3420.1240.26600
Selling & Marketing Expenses 49.5670000000000000000000000000
SG&A 463.9110305.759265.494233.549212.514179.555149.299133.329118.29798.03985.67571.99360.38849.89444.44737.90900.6140.4250.1940.3420.1240.26600
Other Expenses 216.571440.23750.883420.127145.663293.765353.042325.189274.923218.324174.751118.973102.05580.66466.38657.16165.61100.0092.412-78.126-73.6422.8422.175-45.977-10.894
Operating Expenses 720.141579.876501.936427.674377.865326.87288.62240.375216.833193.111164.246140.218119.6299.52584.90374.96662.872147.466106.50895.9311.9082.48749.14945.3011.361-10.894
Operating Income -45.152422.417752.544444.593190.213348.374405.433373.649318.864251.625212.996159.756137.219110.7391.12174.50778.16842.78736.20725.22319.66117.31512.79514.46912.8995.903
Operating Income Ratio -0.0690.7541.4940.9830.4510.9141.191.2961.2261.1151.0550.8860.890.8580.8350.8141.0460.2260.2550.2130.2070.1860.2180.2540.2810.504
Total Other Income Expenses Net -99.773429.196750.883405.025145.663293.765353.042325.189274.923218.324174.751118.973102.05580.66465.2157.16165.611-1.2160.0092.412-78.126-73.7952.8422.175-45.977-10.894
Income Before Tax -144.925206.196722.082410.5171.147329.415388.856362.989309.331242.031203.287150.279130.153102.77283.81669.4474.13441.57135.06323.52518.39615.31211.07314.112.5116.192
Income Before Tax Ratio -0.2230.3681.4330.9070.4050.8651.1421.2591.1891.0721.0070.8330.8440.7960.7680.7590.9920.2190.2460.1990.1940.1640.1890.2470.2720.529
Income Tax Expense -149.7-51.6429.209-12.561-93.5633.4290.646.2953.9080.1138.48213.5499.3822.5955.3993.3721.532035.06323.52518.39615.31211.07314.112.5116.192
Net Income 4.775257.836692.873423.061264.71325.986388.216356.694305.423241.918194.805136.73120.771100.17778.41766.06872.60241.57135.06323.52518.39615.31211.07314.10312.5576.192
Net Income Ratio 0.0070.461.3750.9350.6270.8561.141.2371.1741.0720.9650.7580.7840.7760.7190.7220.9720.2190.2460.1990.1940.1640.1890.2470.2730.529
EPS 0.0070.51.310.80.50.610.730.670.580.460.370.260.230.190.150.130.140.0830.0660.0440.0350.0290.0210.0270.0250.012
EPS Diluted 0.0070.51.310.80.50.610.730.670.580.460.370.260.230.190.150.130.140.0830.0660.0440.0350.0290.0210.0270.0250.012
EBITDA -1.349469.014788.242476.961218.829371.499426.013388.583331.522262.392222.041168.142144.214116.8296.3579.00781.91745.79438.71627.78621.56919.38214.32815.84714.266.713
EBITDA Ratio -0.0020.8371.5651.0540.5180.9751.2511.3471.2751.1621.10.9320.9360.9050.8830.8631.0960.2420.2720.2350.2270.2080.2440.2780.310.573